Coagulation factor-XII induces interleukin-6 by primary lung fibroblasts: a role in idiopathic pulmonary fibrosis?


Journal

American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229

Informations de publication

Date de publication:
01 02 2022
Historique:
pubmed: 8 12 2021
medline: 3 5 2022
entrez: 7 12 2021
Statut: ppublish

Résumé

The mechanisms driving idiopathic pulmonary fibrosis (IPF) remain undefined, however it is postulated that coagulation imbalances may play a role. The impact of blood-derived clotting factors, including factor XII (FXII) has not been investigated in the context of IPF. Plasma levels of FXII were measured by ELISA in patients with IPF and in age-matched healthy donors. Expression of FXII in human lung tissue was quantified using multiplex immunohistochemistry and Western blotting. Mechanistic investigation of FXII activity was assessed in vitro on primary lung fibroblasts using qPCR and specific receptor/FXII inhibition. The functional outcome of FXII on fibroblast migration was examined by high-content image analysis. Compared with 35 healthy donors, plasma levels of FXII were not higher in patients with IPF (

Identifiants

pubmed: 34873957
doi: 10.1152/ajplung.00165.2021
doi:

Substances chimiques

Interleukin-6 0
Factor XII 9001-30-3

Banques de données

figshare
['10.6084/m9.figshare.14403860']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

L258-L272

Auteurs

Jade Jaffar (J)

Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.
Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.

Laura McMillan (L)

CSL Limited, Parkville, Victoria, Australia.

Nick Wilson (N)

CSL Limited, Parkville, Victoria, Australia.

Con Panousis (C)

CSL Limited, Parkville, Victoria, Australia.

Charles Hardy (C)

CSL Limited, Parkville, Victoria, Australia.

Hyun-Jung Cho (HJ)

Biological Optical Microscopy Platform, The University of Melbourne, Melbourne, Victoria, Australia.

Karen Symons (K)

Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.

Ian Glaspole (I)

Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.
Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.

Glen Westall (G)

Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.
Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.

Mae Wong (M)

CSL Limited, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH